Cancer stem cells and fibroinflammatory microenvironment

2019 Activity indicators

  • 1 European project –  EuroNanoMed III.
  • 2 competitive public led project - ISCIII.
  • 4 competitive private projects.
  • 3 competitive HR contracts.
  • 6 publications.
  • IF: 51.59.
  • Publications in D1: 3 (50%).
  • Publications in Q1: 4 (67%).
  • Public entities evaluator: 1 PI.
  • Members of editorial committees: 1 PI.
  • 1 month's stay at other centre: 
    • Health Research Institute of Aragon (Spain)
  • 1 visitors received and 3 months' stay:
    • Maimonides Institute of Biomedical Research of Córdoba (IMIBIC). Spain.

Milestones

  1. Start of the project: "Combating Pancreatic Cancer by Identifying Those Genes Essential for Cancer Stem Cell-Mediated Tumorigenicity". FERO Foundation.
  2. Start of the project: "Photoactivable nanoparticles to immunostimulate the tumour microenvironment in pancreatic cancer (PANIPAC)". Eranet EuroNanoMed III (AC18/00107).
  3. Blasco MT et al., Complete regression of advanced pancreatic ductal adenocarcinoma upon combined inhibition of EGFR and C-Raf. Cancer Cell, 2019; 35(4):573-587. PMID: 30975481, IF: 23.916 Q1/D1.
  4. D'Errico G et al. Tumor-associated macrophage-secreted 14-3-3 signals via AXL to promote pancreatic cancer chemoresistance. Oncogene, 2019, 38(27):5469-5485. PMID: 30936462, IF: 6.634 Q1/D1.
  5. Participation in the España Global Spain campaign. Audiovisual project that presents 'Democracy in motion', a reflection of the reality of the country at a democratic level of modernity and diversity. https://www. youtube.com/watch?v=J-jbYif95vw&app=destop.

Bibliometrics

  Articles Accum. FI Mean FI Articles Q1 or Q2 % in Q1 or Q2 Articles D1 % in D1
2015 6 66.01 6.00 5 83 4 67
2016 5 22.75 4.55 5 100 1 20
2017 2 4.26 2.13 1 50 0 0
2018 7 44.1 7.35 6 86 3 43
2019 6 51.59 8.60 6 100 3 50
  26 188.71 5.73 23 88 11 42

* Only original articles, editorials, guideline and reviews